Open AccessEvolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection
Author(s) -
Mandana Khalili,
Wendy C. King,
David E. Kleiner,
Raymond T. Chung,
Atul K. Bhan,
Marc G. Ghany,
Mark S. Sulkowski,
Mauricio LiskerMelman,
Mamta Jain,
Harry L.A. Janssen,
Amanda Hinerman,
Arun J. Sanyal,
Richard K. Sterling
Publication year - 2021
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciab764
Subject(s) - medicine , fatty liver , steatosis , gastroenterology , coinfection , steatohepatitis , apolipoprotein b , body mass index , hepatitis b virus , cohort , lipoprotein , liver disease , immunology , cholesterol , disease , human immunodeficiency virus (hiv) , virus
Fatty liver disease (FLD) and hepatitis B virus (HBV) infection occur commonly in human immunodeficiency virus (HIV). FLD resolution is associated with improvement in lipoproteins in HIV-uninfected patients. We evaluated changes in FLD in an HBV/HIV-coinfected cohort.